Stock listing
ASX:IME ImExHS Ltd Share Price
Follow ImExHS Ltd into a list and get an email when it puts out news.
Share price · ASX:IME
$0.31 AUD 0.00 (0.0%)
Close on Nov 19, 2026
- Day range
- $0.31 – $0.31 AUDNov 19, 2026
- Volume
- 2,900 sharesNov 19, 2026
- Market cap
- $16.86M AUDAt the close on Nov 19, 2026 · price × 54.40M shares outstanding
- 52-week range
- $0.27 – $0.47 AUDLowest and highest trades, Nov 21, 2025 – Nov 19, 2026
- Traded on an average day
- $5,175 AUDMedian day 9,028 shares · last 3 months, Aug 24, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 24, 2026 – Nov 19, 2026 · ASX:IME · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.31 | 0.00 | 0.0% | $0.31 | $0.31 | $0.31 | 2,900 | |
| $0.31 | -0.02 | -6.1% | $0.31 | $0.31 | $0.31 | 2,500 | |
| $0.33 | 0.00 | 0.0% | $0.32 | $0.33 | $0.32 | 1,535 | |
| $0.33 | 0.00 | 0.0% | $0.33 | $0.33 | $0.33 | 4,382 | |
| $0.33 | -0.015 | -4.3% | $0.33 | $0.33 | $0.33 | 1,579 | |
| $0.345 | 0.00 | 0.0% | $0.345 | $0.345 | $0.345 | 11,480 | |
| $0.345 | 0.00 | 0.0% | $0.345 | $0.345 | $0.345 | 216 | |
| $0.345 | 0.00 | 0.0% | $0.33 | $0.345 | $0.33 | 5,064 | |
| $0.345 | +0.005 | +1.5% | $0.33 | $0.345 | $0.33 | 5,064 | |
| $0.34 | -0.005 | -1.4% | $0.34 | $0.34 | $0.34 | 10,000 | |
| $0.345 | 0.00 | 0.0% | $0.33 | $0.345 | $0.33 | 9,272 | |
| $0.345 | +0.015 | +4.5% | $0.33 | $0.345 | $0.33 | 9,272 | |
| $0.33 | +0.01 | +3.1% | $0.325 | $0.33 | $0.32 | 32,136 | |
| $0.32 | 0.00 | 0.0% | $0.32 | $0.32 | $0.32 | 10,000 | |
| $0.32 | +0.015 | +4.9% | $0.32 | $0.32 | $0.32 | 10,000 | |
| $0.305 | -0.025 | -7.6% | $0.34 | $0.34 | $0.305 | 14,620 | |
| $0.33 | +0.03 | +10.0% | $0.31 | $0.33 | $0.31 | 210,694 | |
| $0.30 | 0.00 | 0.0% | $0.305 | $0.305 | $0.30 | 40,000 | |
| $0.30 | -0.025 | -7.7% | $0.30 | $0.30 | $0.30 | 37,515 | |
| $0.325 | 0.00 | 0.0% | $0.325 | $0.325 | $0.325 | 4,492 | |
| $0.325 | +0.01 | +3.2% | $0.32 | $0.325 | $0.32 | 23,000 | |
| $0.315 | +0.015 | +5.0% | $0.315 | $0.315 | $0.315 | 3,311 | |
| $0.30 | +0.02 | +7.1% | $0.30 | $0.30 | $0.30 | 136 | |
| $0.28 | -0.02 | -6.7% | $0.30 | $0.30 | $0.28 | 7,173 | |
| $0.30 | -0.025 | -7.7% | $0.30 | $0.30 | $0.29 | 23,627 | |
| $0.325 | 0.00 | 0.0% | $0.305 | $0.325 | $0.28 | 20,000 | |
| $0.325 | +0.005 | +1.6% | $0.325 | $0.325 | $0.325 | 10,000 | |
| $0.32 | 0.00 | 0.0% | $0.33 | $0.33 | $0.32 | 20,782 | |
| $0.32 | -0.035 | -9.9% | $0.355 | $0.355 | $0.32 | 3,500 | |
| $0.355 | 0.00 | 0.0% | $0.355 | $0.355 | $0.355 | 162 | |
| $0.355 | +0.005 | +1.4% | $0.35 | $0.355 | $0.35 | 15,000 | |
| $0.35 | 0.00 | 0.0% | $0.35 | $0.35 | $0.35 | 4,838 | |
| $0.35 | 0.00 | 0.0% | $0.35 | $0.35 | $0.35 | 8,784 | |
| $0.35 | 0.00 | 0.0% | $0.35 | $0.35 | $0.345 | 16,928 | |
| $0.35 | +0.04 | +12.9% | $0.31 | $0.35 | $0.31 | 11,999 | |
| $0.31 | 0.00 | 0.0% | $0.31 | $0.31 | $0.31 | 1,629 | |
| $0.31 | 0.00 | 0.0% | $0.31 | $0.31 | $0.305 | 7,203 | |
| $0.31 | 0.00 | 0.0% | $0.305 | $0.31 | $0.305 | 4,171 |
Splits
5 splits since 2007 · ASX:IME · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-50 | Consolidation | |
| 1-for-10 | Consolidation | |
| 1-for-3 | Consolidation | |
| 1-for-10 | Consolidation | |
| 20-for-11 | Split |
- Ticker
- ASX:IME
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Sep 1, 2026
H1 FY26 Results Presentation
Latest deck · Sep 2, 2026
H1 FY26 Earnings Presentation
Earnings · 30 slides
Latest news
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 27, 2026
Closed $0.33 (+3.1%) on Oct 28, 2026
H1 FY26 Results Presentation
Sep 1, 2026
Closed $0.355 (+1.4%) on Sep 2, 2026
Notification of cessation of securities - IME
Sep 1, 2026
Closed $0.35 (0.0%) on Sep 1, 2026
IMEXHS Reports 1H FY26 Results
Aug 27, 2026
Closed $0.35 (0.0%) on Aug 28, 2026
Notice of 1H FY26 Results Presentation
Aug 27, 2026
Closed $0.35 (0.0%) on Aug 28, 2026
Half Yearly Report and Accounts
Aug 27, 2026
Closed $0.35 (0.0%) on Aug 28, 2026
Change in Registered Office
Jul 27, 2026
Closed $0.28 (-8.2%) on Jul 28, 2026
Resignation and Appointment of Company Secretary
Jul 27, 2026
Closed $0.28 (-8.2%) on Jul 28, 2026
IMEXHS Wins Aquila Public Tender in Mexico
May 24, 2026
Closed $0.37 (+2.8%) on May 25, 2026
AGM - Chairman and CEO Addresses and Presentation
May 19, 2026
Closed $0.36 (+2.9%) on May 20, 2026
ImExHS Ltd on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 17 in the last 12 months · 140 in all · newest Oct 27, 2026 · oldest 2016
- Decks
- 40 decks · latest Sep 2, 2026
Valuation
EV/sales 0.5× against a median of 1.2×: 3rd lowest of 10 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- $15.33M AUD
- P/E
- Loss
- EV/sales
- 0.5×
- EV/EBITDA
- 10.1×
- Price/book
- 1.0×
- Gross margin
- 28.7%
- Operating margin
- −2.4%
- Net margin
- −10.0%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| ImExHS Ltd · ASX:IME | US$11.16M | US$10.15M | n/a | 0.5× | 10.1× | 1.0× | −10.0% | 0.0× | n/a |
| Mukdahan International Hospital Public Company Limited · SET:HANN | US$12.20M | US$9.07M | 66.8× | 0.7× | 6.3× | 1.4× | 1.4% | 0.1× | n/a |
| Alzai Health Corp. · TSXV:ALZI | US$11.86M | US$10.93M | n/a | 227× | n/a | 11.2× | n/a | 0.4× | n/a |
| Unipharma Co., Ltd. · TPEX:6621 | US$11.79M | US$8.53M | n/a | 3.2× | n/a | 2.0× | −45.8% | 0.0× | n/a |
| Eukedos SpA · MIL:EUK | US$11.73M | US$11.27M | n/a | 0.2× | 1.2× | 0.4× | −1.4% | 0.0× | n/a |
| Intrasense SA · EURONEXT:ALINS | US$11.00M | US$10.61M | n/a | 3.3× | n/a | n/a | −364.8% | n/a | n/a |
| iTonic Holdings Ltd · NASDAQ:ITOC | US$10.87M | US$8.90M | n/a | 17.0× | n/a | 0.5× | −974.7% | 0.0× | 1.06 |
| Republic Healthcare Limited · HKEX:8357 | US$10.83M | US$9.29M | n/a | 1.2× | n/a | 1.8× | −40.3% | 0.4× | n/a |
| Scandinavian Medical Solutions A/S · OMXCOP:SMSMED | US$10.61M | US$21.25M | 2,780× | 0.6× | 13.9× | 1.0× | 0.0% | 1.0× | n/a |
| Medilines Distributors, Inc. · PSE:MEDIC | US$10.33M | US$9.37M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | n/a |
| KT Medical Service Public Company Limited · SET:KTMS | US$10.25M | US$8.24M | 9.6× | 0.4× | 2.8× | 0.6× | 5.1% | 0.0× | n/a |
| Median of the others | US$10.94M | US$9.33M | 66.8× | 1.2× | 4.6× | 1.0× | −20.9% | 0.0× | 1.06 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.37 AUD · Analysts' mean
- EPS, year to Dec 2026
- -0.000 · 1 analyst
- Revenue, year to Dec 2026
- 32.85M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Germán Arango | CEO & Co-Founder |
| Reena Minhas | Chief Financial Officer |
| Jorge Marín | Chief Medical Officer & Co-Founder |
| Orlando Jóven | Chief Operations Officer |
Board
| Director | Role |
|---|---|
| Doug Flynn | Non-Executive Chairman |
| Carlos Palacio | Non-Executive Director |
| Damian Banks | Non-Executive Director |
| Doug Lingard | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Nov 3, 2025 | +3.7% |
| Q2 2025 | Aug 28, 2025 · Before open | −2.2% |
| Quarter to Mar 31, 2025 | Apr 30, 2025 | 0.0% |
| Q4 2024 | Mar 30, 2025 | 0.0% |
| Quarter to Sep 30, 2024 | Nov 27, 2024 | −5.6% |
| Q2 2024 | Aug 29, 2024 | 0.0% |
| Quarter to Mar 31, 2024 | May 29, 2024 | 0.0% |
| Q4 2023 | Feb 28, 2024 | −4.6% |
| Quarter to Sep 30, 2023 | Oct 30, 2023 · Before open | −1.4% |
| Q2 2023 | Aug 31, 2023 · After close |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | Apr 28, 2023 · After close | −3.7% |
| Q4 2022 | Feb 28, 2023 · Before open | 0.0% |
| Q3 2022 | Oct 31, 2022 · Before open | 0.0% |
| Q2 2022 | Aug 30, 2022 · Before open | +7.9% |
| Q1 2022 | May 18, 2022 | −1.4% |
| Q4 2021 | Feb 28, 2022 · Before open | 0.0% |
| Q3 2021 | Dec 1, 2021 | +6.3% |
| Q2 2021 | Aug 30, 2021 | −11.0% |
| Q4 2020 | Feb 25, 2021 | −3.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 FY26 Earnings Presentation | Earnings | 30 slides | Sep 2, 2026 |
| Shareholder Meeting (May 2026) | Shareholder meeting | 51 slides | May 20, 2026 |
| Investor Presentation (February 2026) | Investor deck | 25 slides | Feb 27, 2026 |
| Q3 FY25 Earnings Presentation | Earnings | 20 slides | Nov 4, 2025 |
| H1 2025 Earnings Presentation | Earnings | 28 slides | Sep 2, 2025 |
| Shareholder Meeting (May 2025) | Shareholder meeting | 41 slides | May 19, 2025 |
| FY2024 Earnings Presentation | Earnings | 38 slides | Apr 3, 2025 |
| FY2024 Earnings Presentation | Earnings | 25 slides | Feb 28, 2025 |
| H1 FY2024 Earnings Presentation | Earnings | 24 slides | Aug 30, 2024 |
| Shareholder Meeting (April 2024) | Shareholder meeting | 44 slides | Apr 23, 2024 |
All 40 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2024) | Investor deck | 24 slides | Feb 29, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 13 slides | Jan 30, 2024 |
| Shareholder Meeting (September 2023) | Shareholder meeting | 10 slides | Sep 15, 2023 |
| H1 FY2023 Earnings Presentation | Earnings | 22 slides | Aug 31, 2023 |
| Shareholder Meeting (May 2023) | Shareholder meeting | 37 slides | May 16, 2023 |
| Non-Deal Roadshow (March 2023) | Roadshow | 27 slides | Mar 23, 2023 |
| Investor Presentation (February 2023) | Investor deck | 25 slides | Feb 28, 2023 |
| H1 2022 Earnings Presentation | Earnings | 30 slides | Aug 30, 2022 |
| Investor Presentation (August 2022) | Investor deck | 35 slides | Aug 3, 2022 |
| Shareholder Meeting (May 2022) | Shareholder meeting | 32 slides | May 19, 2022 |
| Non-Deal Roadshow (March 2022) | Roadshow | 17 slides | Mar 21, 2022 |
| Investor Presentation (February 2022) | Investor deck | 31 slides | Feb 28, 2022 |
| Morgans Technology Conference 2021 | Conference | 21 slides | Nov 24, 2021 |
| Shareholder Meeting (September 2021) | Shareholder meeting | 22 slides | Sep 29, 2021 |
| H1 2021 Earnings Presentation | Earnings | 31 slides | Aug 30, 2021 |
| Investor Presentation (July 2021) | Investor deck | 16 slides | Jul 26, 2021 |
| Shareholder Meeting (May 2021) | Shareholder meeting | 34 slides | May 13, 2021 |
| Coffee MicroCaps (March 2021) | Conference | 19 slides | Mar 18, 2021 |
| FY2020 Earnings Presentation | Earnings | 33 slides | Feb 26, 2021 |
| Investor Presentation (October 2020) | Investor deck | 25 slides | October 2020 |
| H1 2020 Earnings Presentation | Earnings | 38 slides | Aug 31, 2020 |
| Shareholder Meeting (May 2020) | Shareholder meeting | 27 slides | May 21, 2020 |
| Investor Presentation (April 2020) | Investor deck | 24 slides | Apr 1, 2020 |
| Microcap Conference (October 2019) | Conference | 23 slides | Oct 23, 2019 |
| Investor Presentation (May 2019) | Investor deck | 26 slides | May 21, 2019 |
| Investor Presentation (May 2019) | Investor deck | 11 slides | May 6, 2019 |
| Investor Presentation (March 2019) | Investor deck | 20 slides | Mar 5, 2019 |
| Investor Presentation (November 2018) | Investor deck | 22 slides | Nov 15, 2018 |
| Corporate Update (September 2018) | Corporate update | 24 slides | Sep 10, 2018 |
| Investor Presentation (May 2018) | Investor deck | 21 slides | May 17, 2018 |
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.0M | 26.6M | 19.7M | 17.1M | 13.4M | 10.9M | 7.74M | 5.78M | 3.55M | 80.1K |
| Cost of revenue | 20.7M | 15.5M | 16.2M | 13.6M | 8.20M | 6.46M | 5.04M | 3.40M | 2.90M | 1.77M |
| Gross profit | 8.31M | 11.0M | 3.50M | 3.52M | 5.22M | 2.70M | 2.70M | 2.38M | 648.8K | -1.69M |
| Research and development | 2.26M | 2.92M | 2.44M | 1.53M | 1.11M | 646.7K | 2.12M | 1.34M | 19.5K | 280.7K |
| Selling, general and administrative | 8.29M | 7.46M | 5.54M | 5.61M | 6.09M | 4.42M | 3.78M | 2.79M | 243.6K | 2.41M |
| Operating income | -697.6K | -367.1K | -2.70M | -2.42M | -3.14M | -2.31M | -5.22M | -1.17M | -592.0K | -3.98M |
| Depreciation and amortization | 2.22M | 2.15M | 2.43M | 1.76M | 1.24M | 1.02M | 825.9K | 306.7K | 244.2K | 20.8K |
| EBITDA | 1.52M | 1.78M | -268.7K | -664.7K | -1.91M | -1.28M | -4.40M | -862.3K | -347.8K | -3.96M |
| Interest expense | 375.0K | 468.9K | 332.1K | 442.7K | 311.1K | 1.21M | 899.5K | 528.1K | 0 | 0 |
| Income before tax | -3.04M | -2.57M | -4.28M | -2.95M | -4.56M | -3.53M | -6.04M | -4.79M | 68.5K | -4.49M |
| Income tax | -156.6K | 57.6K | 172.7K | 92.4K | 143.4K | 87.9K | -40.3K | 91.8K | -661.0K | 1.01M |
| Net income | -2.88M | -2.63M | -4.19M | -3.04M | -4.70M | -3.62M | -6.00M | -4.89M | 68.5K | -4.49M |
| Earnings per share, basic | -0.06 | -0.06 | -0.10 | -0.09 | -0.15 | -0.15 | -0.31 | -0.37 | 0.01 | -98.56 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.30M | 2.07M | 2.36M | 1.91M | 4.19M | 10.8M | 7.15M | 2.45M | 964.0K | 187.7K |
| Short-term investments | 274.8K | |||||||||
| Receivables | 7.73M | 5.89M | 5.33M | 6.22M | 6.15M | 4.03M | 2.69M | 3.36M | 574.7K | 156.6K |
| Inventory | 146.2K | 328.0K | 112.0K | 96.8K | 84.4K | 389.7K | 107.4K | 811.3K | 297.2K | 479.1K |
| Current assets | 13.4M | 9.26M | 8.92M | 8.51M | 10.7M | 15.2M | 10.9M | 7.14M | 1.54M | 348.4K |
| Property, plant and equipment | 3.12M | 3.30M | 4.65M | 3.73M | 4.50M | 3.45M | 3.42M | 1.59M | 446.5K | 499.7K |
| Goodwill | 3.35M | 4.61M | 4.80M | 4.86M | 5.42M | |||||
| Total assets | 23.7M | 21.8M | 22.7M | 21.0M | 25.0M | 20.8M | 14.8M | 9.26M | 1.55M | 496.1K |
| Accounts payable | 3.55M | 3.12M | 2.45M | 2.03M | 2.44M | 1.46M | 870.2K | 1.90M | 74.1K | 539.2K |
| Current liabilities | 7.76M | 6.89M | 6.37M | 4.48M | 6.35M | 4.46M | 3.65M | 3.32M | 89.1K | 822.2K |
| Long-term debt | 13.9K | 365.3K | 215.7K | 542.8K | 1.29M | 728.0K | 826.9K | 0 | 250.0K | |
| Total debt | 566.3K | 1.19M | 1.29M | 1.12M | 2.40M | 1.70M | 2.10M | 188.5K | 457.4K | 250.0K |
| Total liabilities | 7.86M | 7.33M | 6.67M | 5.09M | 8.36M | 5.27M | 4.48M | 3.41M | 89.1K | 822.2K |
| Shareholders' equity | 15.9M | 14.5M | 16.0M | 15.9M | 16.7M | 15.5M | 10.3M | 5.85M | 1.46M | -326.1K |
| Shares outstanding | 51.2M | 45.0M | 41.7M | 35.6M | 31.1M | 24.9M | 19.5M | 13.2M | 10.5M | 45.6K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 564.7K | -634.7K | 2.61M | -2.20M | -2.97M | -1.47M | -4.09M | -1.54M | -109.9K | -3.65M |
| Capital spending | -320.5K | -1.06M | -2.20M | -2.03M | -2.56M | -2.19M | -2.30M | -1.32M | -370.5K | -29.7K |
| Free cash flow | 244.2K | -1.69M | 414.6K | -4.23M | -5.53M | -3.65M | -6.39M | -2.86M | -480.3K | -3.68M |
| Cash from investing | -1.19M | -765.9K | -2.13M | -2.22M | -3.39M | -2.19M | -2.46M | -1.32M | -696.4K | -29.7K |
| Cash from financing | 1.68M | 1.18M | -98.6K | 2.25M | -161.8K | 7.40M | 11.3M | 5.26M | 1.47M | 244.4K |
| Dividends paid | -1.97M | -101.9K | -6.93M | -2.38M | ||||||
| Share buybacks | -206.4K | -122.8K | -12.8K | -362.8K | -25.6K | -575.5K | -675.8K | 5.50M | -84.0K | -7.60K |
| Change in cash | 1.23M | -289.8K | 449.9K | -2.27M | -6.61M | 3.65M | 4.70M | 2.44M | 776.2K | -3.44M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
| H1 FY26 Results Presentation | Sep 1, 2026 | Other filings | ASX |
| Notification of cessation of securities - IME | Sep 1, 2026 | Notification letter | ASX |
| IMEXHS Reports 1H FY26 Results | Aug 27, 2026 | Results | ASX |
| Notice of 1H FY26 Results Presentation | Aug 27, 2026 | Results | ASX |
| Half Yearly Report and Accounts | Aug 27, 2026 | Interim report | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Jul 30, 2026 | Quarterly report | ASX |
| Change in Registered Office | Jul 27, 2026 | Other filings | ASX |
| Resignation and Appointment of Company Secretary | Jul 27, 2026 | Management or board change | ASX |
| IMEXHS Wins Aquila Public Tender in Mexico | May 24, 2026 | Operations update | ASX |
All 140 filings
Cap table
Built by 6ix from ImExHS Ltd’s releases
- Common shares
- 54,395,712
- Fully diluted
- 54,395,712
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 54,395,712 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 54,395,712 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carlos Palacio | Non-Executive Director · Since at least Nov 5, 2026 |
| Damian Banks | Non-Executive Director · Since at least Nov 5, 2026 |
| Doug Flynn | Non-Executive Chairman · Since at least Nov 5, 2026 |
| Doug Lingard | Non-Executive Director · Since at least Nov 5, 2026 |
| Germán Arango | CEO & Co-Founder · Since at least Aug 28, 2026 |
| Jorge Marín | Chief Medical Officer & Co-Founder · Since at least Nov 5, 2026 |
| Orlando Jóven | Chief Operations Officer · Since at least Nov 5, 2026 |
| Reena Minhas | Chief Financial Officer · Since at least Jul 28, 2026 |
Log in to ask 6ix AI your own questions about ImExHS Ltd.